09-06-2025 17:06 via drugs.com

Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea

MONDAY, June 9, 2025 -- Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients preferring tirzepatide, according...
Read more »

Pharmaceutical Industry news



Doctors' Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
Few Adolescents With Obesity Prescribed Obesity Medications
Huntington Disease Digital Motor Score Can Enhance Progression Detection
Decline in Youth Physical Fitness Seen in Association With Pandemic
Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
Mindfulness, Transcranial Stimulation Promising for Urgency Urinary Incontinence
Most TikTok Videos on Inflammatory Bowel Disease Are Low Quality
Adverse Childhood Experiences Tied to Endometriosis Risk
Circulating Tumor DNA Can Be Detected Several Years Before Cancer Diagnosis
Childhood Cancer Treatment, Genetics Contribute to Subsequent Neoplasm Risk
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
Desktop versie